Glanzmann Thrombasthenia has emerging NIH research funding with 2 grants totaling $5.8M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Glanzmann Thrombasthenia. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
6 clinical trials registered but no NIH-funded clinical or translational research grants found for Glanzmann thrombasthenia. Trials may be industry-sponsored or funded through non-NIH sources.
7 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for Glanzmann thrombasthenia. Existing research activity suggests this may be a viable area for grant applications.
28 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for Glanzmann thrombasthenia. Existing research activity suggests this may be a viable area for grant applications.
13 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for Glanzmann thrombasthenia. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Glanzmann Thrombasthenia as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Glanzmann Thrombasthenia.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.